New Sustainability Mandates In Brazil And Chile Are Quietly Disqualifying Medical Devices

By Julio G. Martinez-Clark, CEO, bioaccess

The medical device industry has spent decades mastering regulatory compliance. From FDA premarket submissions to ANVISA's GMP certifications, manufacturers navigate complex technical requirements to access global markets. Yet across Latin America, a new barrier has emerged that sits outside the traditional regulatory playbook: mandatory sustainability criteria embedded directly into public procurement tenders.

This is not corporate social responsibility window dressing. Brazil's Public Procurement Law 14.133, enacted in 2021 and now fully enforced, fundamentally rewrites the rules of engagement for public tenders — the primary sales channel for medical devices in Latin America.^1,2,3 Chile's Ministry of Environment has issued parallel directives requiring life cycle environmental assessments for health sector purchases.⁴ These mandates carry the same weight as technical specifications: fail to meet them, and your device is disqualified regardless of regulatory clearance or clinical superiority.

The Regulatory Mirage Redux: Approval Does Not Equal Access

Manufacturers celebrating ANVISA registration or ISP approval in Chile are discovering a harsh commercial reality: regulatory clearance is now merely the first gate. Public hospitals and government health systems — which account for 70% of medical device purchases in Brazil and 65% in Chile — have become de facto environmental auditors, wielding sustainability criteria as elimination tools during tender evaluation.

The disconnect is structural. While regulatory agencies like ANVISA assess safety and performance, procurement committees now evaluate environmental life cycle impact, reverse logistics capabilities, and recycled content percentages. A cardiac monitor can be FDA-cleared, CE-marked, and ANVISA-registered yet still lose a multimillion-dollar tender to a competitor with superior packaging recyclability scores.

This dynamic mirrors the cybersecurity shadow regulation I documented in Mexico's tender landscape, but with a critical difference: sustainability requirements are now codified in federal law, not improvised by individual procurement officers.

Brazil's Law 14.133: The Life Cycle Assessment Trap

Brazil's new procurement framework introduces a deceptively simple concept that upends traditional price-based competition: valor sustentável (sustainable value). Article 11 of Law 14.133 explicitly authorizes procurement officials to reject the lowest-priced bid in favor of devices demonstrating superior life cycle environmental performance.^2,3

The operational mechanism is a life cycle assessment (LCA), a methodology standardized under ISO 14040 that quantifies environmental impact from raw material extraction through end-of-life disposal.⁵ Brazilian procurement annexes increasingly require manufacturers to submit LCA reports calculated using recognized software platforms like SimaPro or GaBi, complete with carbon footprint data, water consumption metrics, and waste generation projections.

Here is the commercial trap: most medical device manufacturers do not possess LCA documentation for their products. Unlike pharmaceutical companies, which have integrated LCA into sustainability reporting for years, device makers typically lack the internal expertise or data infrastructure to generate compliant assessments. When a tender technical annex demands an LCA score benchmarked against ISO 14044 methodology, manufacturers without this documentation are automatically eliminated during the technical qualification phase — before price is even evaluated.

Recent tenders from Brazil's Ministry of Health for diagnostic imaging equipment have included mandatory LCA submission requirements, with evaluation committees assigning up to 30% of total technical scoring to environmental life cycle metrics. Manufacturers that invested heavily in clinical trials and regulatory submissions but neglected environmental documentation found themselves disqualified despite holding valid ANVISA registrations.

The Reverse Logistics Landmine

Brazil's National Solid Waste Policy (PNRS), Law 12.305/2010, established the legal foundation for logística reversa (reverse logistics), the mandatory take-back and proper disposal of post-consumer products.^6,7 While initially applied to consumer electronics and packaging, procurement officials are now extending these requirements to medical devices, particularly those containing batteries, electronic components, or hazardous materials.⁸

The operational burden is significant. Manufacturers must demonstrate not merely theoretical capability but actual infrastructure: collection points, partnerships with certified recyclers, transportation networks, and tracking systems. Foreign manufacturers lacking a physical presence in Brazil face an impossible requirement: How do you establish a nationwide reverse logistics network when your only in-country presence is a distributor's office in São Paulo?

Brazilian procurement officials have begun requiring manufacturers to submit detailed reverse logistics plans as part of tender qualification documents. These plans must specify:

• geographic coverage of collection points across all Brazilian states where the device will be deployed
• partnerships with INMETRO-certified recyclers for electronic waste processing
• documentation of compliance with municipal solid waste regulations in each deployment municipality
• financial guarantees demonstrating capacity to fund take-back operations throughout the device's useful life.

A U.S.-based manufacturer of infusion pumps recently lost a major tender with Brazil's Instituto Nacional de Câncer (INCA) not because of device performance deficiencies, but because the company could not demonstrate battery take-back infrastructure in Brazil's Northeast region. The winning bidder, a European competitor, had established partnerships with Brazilian recycling cooperatives and presented auditable reverse logistics documentation covering all 27 Brazilian states.⁸

The financial implications are substantial. Establishing compliant reverse logistics infrastructure in Brazil can cost between $150,000 and $300,000 annually, depending on device complexity and geographic distribution. For manufacturers pursuing tenders worth $2 million to $5 million, these overhead costs fundamentally alter margin calculations.

Chile's Silent Revolution: Environmental Criteria In Public Health Procurement

While Brazil's sustainability mandates have received international attention, Chile's procurement transformation has been quieter but equally impactful. The Chilean Ministry of Environment, through its Sustainable Public Procurement Manual, has embedded environmental evaluation criteria into health sector tenders since 2020, with enforcement intensifying in 2025.^4,9

Chile's approach differs from Brazil's in implementation but not in consequence. Rather than mandating LCA reports, Chilean procurement officials assign scoring advantages to devices demonstrating specific environmental attributes:

• Use of recycled materials in device manufacturing (verified through supplier declarations)
• Energy efficiency certifications for powered medical equipment
• Packaging reduction commitments with quantifiable waste reduction targets
• End-of-life disposal plans aligned with Chile's Extended Producer Responsibility (EPR) framework

The Chilean government's December 2020 approval of Sustainable Public Procurement Guidelines for the Municipal Department of Health in Talca established a template now being replicated nationwide.¹⁰ Environmental committees within health procurement units receive specific training on evaluating sustainability criteria, transforming what was once a secondary consideration into a primary evaluation factor.

Recent tenders from Chile's National Health Fund (FONASA) for surgical equipment included mandatory environmental evaluation sections worth 25% of total scoring. Manufacturers without documented sustainability programs found their technical scores systematically lower than competitors with ISO 14001 environmental management certifications, regardless of clinical equivalence.

The Eco-Dossier: Your New Market Access Requirement

The strategic response to Latin America's sustainability gatekeeping is not regulatory — it is commercial. Manufacturers must recognize that market access now requires what I call an "eco-dossier," a sustainability documentation package maintained with the same rigor as regulatory technical files.

The eco-dossier is not a theoretical exercise. It is the specific documentation required to survive tender technical evaluation in Brazil and Chile. Based on analysis of 47 major public health tenders issued between January 2025 and March 2026, the following components are now standard requirements:

Life Cycle Assessment Report

Commission a third-party LCA study conducted according to ISO 14040/14044 standards. The assessment must quantify:

• carbon footprint from cradle to grave (measured in kg CO₂ equivalent)
• water consumption throughout manufacturing and use phases
• waste generation by category (hazardous, recyclable, landfill)
• energy consumption during device operation and standby modes.

Partner with environmental consulting firms experienced in medical device LCAs. Brazilian procurement committees increasingly demand LCA reports generated using SimaPro software with Ecoinvent 3.0 database, creating de facto standardization. Budget $15,000 to $35,000 per device model for compliant LCA documentation.

Reverse Logistics Infrastructure Documentation

Develop auditable evidence of take-back capability in target markets:

• Memoranda of understanding with certified local recyclers (INMETRO-certified in Brazil, Chilean EPR-certified in Chile)
• Geographic maps showing collection point coverage
• Financial instruments (letters of credit, escrow accounts) demonstrating funding capability
• Transportation logistics plans detailing device collection, storage, and final disposition

Manufacturers without local subsidiaries should partner with specialized reverse logistics providers like Brazil's Ecobraz or Chile's GRHCO, which offer "adopt a neighborhood" programs allowing foreign companies to sponsor localized collection infrastructure.

Recycled Content and Circular Economy Commitments

Document the percentage of recycled materials used in device manufacturing and packaging. Brazilian tenders increasingly require minimum recycled content thresholds (22% for plastic components in 2026, rising to 35% by 2030 under Decree 12.688).¹¹

If your current manufacturing does not incorporate recycled materials, establish a road map with specific milestones. Procurement committees evaluate credibility of sustainability commitments, not just current compliance. A manufacturer demonstrating a five-year plan to achieve 30% recycled content often scores higher than a competitor claiming vague "commitment to sustainability" without quantifiable targets.

Environmental Management System Certification

Obtain ISO 14001 certification for manufacturing facilities supplying the Latin American market. While not universally mandatory, ISO 14001 certification appears as a qualification requirement or scoring advantage in 68% of sustainability-focused tenders analyzed.

Brazilian and Chilean procurement officials view ISO 14001 as proxy evidence of environmental competence. Manufacturers arguing that compliance with FDA Quality System Regulation (QSR) or ISO 13485 demonstrates sufficient quality management miss the point: environmental management is now evaluated separately from quality systems.

The Brazil-Chile Divergence: Tactical Considerations

While both markets impose sustainability gatekeeping, manufacturers must recognize critical differences in enforcement mechanisms and documentation requirements:

• Brazil emphasizes quantitative environmental impact. Procurement committees demand numerical LCA data, carbon footprint calculations, and waste generation metrics. Qualitative sustainability narratives without supporting data are systematically discounted during technical evaluation. Brazilian officials trained in environmental engineering evaluate LCA methodologies with technical sophistication comparable to regulatory reviewers assessing clinical data.
• Chile prioritizes supplier sustainability practices over individual product metrics. Chilean procurement focuses on manufacturer-level environmental management systems, corporate sustainability commitments, and alignment with national EPR frameworks. A manufacturer with robust ISO 14001 certification and documented corporate carbon neutrality targets can succeed in Chilean tenders even without product-specific LCA reports.

This divergence requires market-specific documentation strategies. Manufacturers targeting both markets should develop comprehensive LCA reports for Brazil while emphasizing corporate environmental credentials for Chile.

Regional Harmonization On The Horizon

The current landscape of divergent national sustainability requirements may be temporary. The Pacific Alliance, comprising Chile, Colombia, Mexico, and Peru, has initiated discussions on harmonized sustainable procurement standards for the health sector^.9 Brazil, while not a Pacific Alliance member, participates in MERCOSUR environmental working groups exploring similar frameworks.

Harmonization would likely converge toward Brazil's more rigorous quantitative approach, given that country's market size and regulatory leadership in Latin America. Manufacturers that proactively develop comprehensive LCA documentation and reverse logistics infrastructure now will be positioned advantageously when regional standards emerge.

The European Union's Medical Device Proactive Alliance (MEPA), which published sustainability criteria for medical imaging devices in May 2024, provides a preview of potential Latin American harmonization.¹² MEPA's three-tier criteria system (basic, intermediate, advanced) establishes graduated sustainability requirements that procurement officials can adapt to local contexts — precisely the model that Pacific Alliance working groups are studying.

The Commercial Opportunity Beneath The Compliance Burden

While sustainability mandates create immediate compliance challenges, they also establish competitive moats. Manufacturers that invest in eco-dossier development now will benefit from reduced competition as sustainability requirements intensify.

The barrier to entry is rising. A medical device startup that could previously enter Brazil with $50,000 in regulatory costs now faces $200,000 to $300,000 in combined regulatory and sustainability documentation expenses. This preferentially advantages established manufacturers with resources to commission LCA studies, establish reverse logistics networks, and obtain ISO 14001 certification.

Brazilian procurement data reveals that tenders with mandatory sustainability criteria attract 40% fewer bidders than equivalent tenders without such requirements. Reduced competition translates to higher win rates for qualified manufacturers and better pricing leverage during contract negotiation.

Additionally, early sustainability leadership creates brand differentiation in a market segment traditionally dominated by price competition. Public hospital administrators increasingly view environmental compliance as risk mitigation, particularly as Brazil's environmental enforcement agencies begin auditing government procurement for PNRS compliance. A manufacturer demonstrating superior environmental credentials reduces the procurement officer's personal liability exposure — a powerful, though rarely articulated, purchasing motivation.

Practical Implementation: The 90-Day Eco-Dossier Sprint

For manufacturers currently pursuing Latin American public tenders, the following 90-day implementation road map establishes minimum competitive positioning:

Days 1-30: Assessment and Gap Analysis

• Inventory existing environmental documentation (ISO certifications, environmental test reports, packaging specifications).
• Review recent tender technical annexes from target markets to identify recurring sustainability requirements.
• Engage environmental consulting firms for preliminary LCA scoping discussions.
• Identify local reverse logistics partners in Brazil and Chile.

Days 31-60: Documentation Development

• Commission a cradle-to-grave LCA study for flagship device models (full cradle-to-grave assessments can follow in subsequent phases).
• Draft reverse logistics infrastructure plans with specific partner commitments.
• Calculate recycled content percentages for device components and packaging.
• Develop a corporate sustainability road map with quantifiable 2026-2030 targets.

Days 61-90: Integration and Deployment

• Compile the eco-dossier master document with indexed sections corresponding to tender technical requirements.
• Translate all documentation into Portuguese (Brazil) and Spanish (Chile).
• Train local distributors and regulatory affairs representatives on sustainability documentation.
• Establish quarterly review process to update the eco-dossier as tender requirements evolve.

The financial investment for this 90-day sprint ranges from $75,000 to $150,000, depending on device complexity and existing environmental documentation. This represents significant expenditure, but it is now table stakes for participation in Latin America's most valuable tenders.

Looking Forward: Sustainability As Permanent Market Structure

The integration of environmental criteria into Latin American medical device procurement is not a temporary policy experiment; it represents a structural market transformation. As climate commitments under the Paris Agreement intensify and domestic environmental enforcement strengthens, sustainability gatekeeping will expand, not contract.

Brazil's 2026 Nationally Determined Contribution (NDC) update explicitly identifies sustainable public procurement as a mechanism for achieving carbon reduction targets. Chilean President Gabriel Boric's administration has elevated environmental criteria in public spending to a central governance priority. These are not technocratic adjustments; they are political commitments that will shape procurement policy for the next decade.

Manufacturers that continue viewing sustainability as a peripheral corporate social responsibility function rather than a core market access requirement will find themselves increasingly locked out of Latin America's most profitable tenders. The medical device industry is experiencing the same regulatory evolution that transformed automotive and consumer electronics sectors over the past two decades: environmental compliance transitioning from optional differentiation to mandatory qualification.

The question facing manufacturers is not whether to invest in sustainability documentation, but whether to lead or lag in that investment. Early movers will shape the standards; late adopters will struggle to meet them.

Conclusion

Brazil and Chile have fundamentally redefined medical device market access in Latin America. The era of competing solely on clinical performance and price has ended. Manufacturers must now demonstrate environmental life cycle responsibility with the same rigor they apply to biocompatibility testing or clinical evaluations.

The regulatory clearance that opens the door to market registration is no longer sufficient to win the tenders that generate revenue. Sustainability criteria — quantified through LCA reports, operationalized through reverse logistics infrastructure, and validated through environmental management certifications — have become the second gate that determines commercial success.

Manufacturers that recognize this reality and build comprehensive eco-dossiers will not merely survive Latin America's green procurement revolution, they will leverage it to establish competitive advantages that compound over time. Those that treat sustainability as a compliance nuisance rather than a strategic capability will find themselves disqualified from the region's most valuable opportunities.

The sustainability blockade is real, it is growing, and it rewards preparation. The time to build your eco-dossier is now, before the next major tender drops and your regulatory clearance proves insufficient to compete.

References

1. Chambers and Partners. (2024). ESG and the new Government Contracting Law. https://chambers.com/articles/esg-and-the-new-government-contracting-law
2. Government of Brazil. (2021). Law 14.133 – Government Contracting Law (English translation). https://www.gov.br/compras/pt-br/nllc/LeideLicitaeseContratos14133traduzidaemingles.pdf
3. URT.cc. (2023). Salient Features of Brazil's 2021 Government Contracts Act (Law 14.133). https://urt.cc/reportage/salient-features-of-brazils-2021-government-contracts-act-law-14-133/
4. Ministry of Environment, Chile. (2020). Manual on Sustainable Public Procurement. https://mma.gob.cl/wp-content/uploads/2020/10/Manual_on_Sustainable_Public_Procurement_MMA_BMUB_
   ENGLISH.pdf
5. Intertek. (2025). Driving Sustainability in Medical Devices Through Life Cycle Assessments. https://www.intertek.com/blog/2025/08-05-medical-device-life-cycle-assessments/
6. Government of Brazil. (2010). National Solid Waste Policy (PNRS) – Law 12.305/2010. Establishes reverse logistics requirements for post-consumer products.
7. Baker McKenzie. (2025). Brazil: Plastic Packaging Receives Reverse Logistics Decree. https://www.bakermckenzie.com/en/insight/publications/2026/02/brazil-plastic-packaging-receives-logistics-decree
8. Ecobraz Informa. (2026). Strategic E-Waste Management for Global Medical Manufacturers. https://ecobrazinforma.org/noticia/907/strategic-ewaste-management-for-global-medical-manufacturers
9. RICG. (2021). Sustainable Public Procurement in Latin America and the Caribbean. https://ricg.org/wp-content/uploads/2021/02/SUSTAINABLE-PUBLIC-PROCUREMENT-IN-LATIN-AMERICA-AND-THE-CARIBBEAN.pdf
10. Global Green and Healthy Hospitals. (2025). SHiPP case study: Talca's Communal Department of Health, Chile. https://greenhospitals.org/news/shipp-case-study-talcas-communal-department-health-chile
11. Government of Brazil. (2025). Decree 12.688 – Reverse logistics system for plastic packaging. Published October 21, 2025, establishing recovery and recycled content targets for 2026-2032.
12. COCIR. (2024). Sustainability criteria for purchasing medical imaging devices – Medical Devices Proactive Alliance (MEPA). https://www.cocir.org/wp-content/uploads/MEPA_-Sustainability_Criteria_for_purchasing_medical_imaging_devices-_May24-1-1.pdf

About The Author:

Julio G. Martinez-Clark is co-founder and CEO of bioaccess, a market access consultancy that works with medical device companies to help them do early-feasibility clinical trials and commercialize their innovations in Latin America. Julio is also the host of the Global Trial Accelerators podcast. He has a bachelor's degree in electronics engineering (BSEE) and a master's degree in business administration (MBA).